Small personalized vaccine trial sees progress in late-stage kidney cancer - Endpoints News
2/5/2025
Small personalized vaccine trial sees progress in late-stage kidney cancer Endpoints NewsA neoantigen vaccine generates antitumour immunity in renal cell carcinoma Nature.comCancer vaccine shows promise for patients with stage III and IV kidney cancer Medical XpressPersonalized cancer vaccine shows potential in kidney cancer STATNeoantigen Vaccine Shows Promise for Treating Advanced Kidney Cancer Inside Precision Medicine...
Original
Tags: cancer | iii | iv | news | potential | sees | shows | small | stage | trial